N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide

C141H140Cl2F16N32O19S5 — CID 159983144

About N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide

N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide (PubChem CID 159983144) has the molecular formula C141H140Cl2F16N32O19S5 and a molecular weight of 3122.08 g/mol. Its IUPAC name is N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide.

Molecular Properties

• Compound Name: N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide
• PubChem CID: 159983144
• Molecular Formula: C141H140Cl2F16N32O19S5
• Molecular Weight: 3122.08 g/mol
• Exact Mass: 3118.87
• IUPAC Name: N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide
• SMILES: CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2cc(C(C)(C)C)ncn2)s1.CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)s1.CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)s1.C[C@H](CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)s1.Cc1ccc(NC(=O)c2cc([C@@H](C)CC(=O)c3cc(N4CCOCC4)ncn3)no2)cc1C(F)(F)F.Cc1ccc(NC(=O)c2cnc(C(C)CC(=O)c3cc(N4CCOCC4)ncn3)s2)cc1C(F)(F)F
• InChI: InChI=1S/C24H24F3N5O4.C24H24F3N5O3S.C24H29N7O3S.2C23H21ClF3N5O3S.C23H21F4N5O3S/c1-14-3-4-16(10-17(14)24(25,26)27)30-23(34)21-11-18(31-36-21)15(2)9-20(33)19-12-22(29-13-28-19)32-5-7-35-8-6-32;1-14-3-4-16(10-17(14)24(25,26)27)31-22(34)20-12-28-23(36-20)15(2)9-19(33)18-11-21(30-13-29-18)32-5-7-35-8-6-32;1-15(9-17(32)16-10-21(29-13-26-16)31-5-7-34-8-6-31)23-25-12-18(35-23)22(33)30-20-11-19(24(2,3)4)27-14-28-20;3*1-13(8-18(33)17-10-20(30-12-29-17)32-4-6-35-7-5-32)22-28-11-19(36-22)21(34)31-14-2-3-16(24)15(9-14)23(25,26)27/h3-4,10-13,15H,5-9H2,1-2H3,(H,30,34);3-4,10-13,15H,5-9H2,1-2H3,(H,31,34);10-15H,5-9H2,1-4H3,(H,27,28,30,33);3*2-3,9-13H,4-8H2,1H3,(H,31,34)/t15-;;;13-;;/m0..1../s1
• InChIKey: OGAKSHYZGUCCDL-WINPIKCYSA-N
• XLogP: 27.17
• TPSA: 622.78 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 50
• Rotatable Bonds: 42
• Heavy Atoms: 215
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3122.08
LogP ≤ 5	27.17
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	50

Frequently Asked Questions

What is the IUPAC name of N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide?

The IUPAC name of N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide (CID 159983144) is N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide.

What is the SMILES notation for N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide?

The canonical SMILES for N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide is CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2cc(C(C)(C)C)ncn2)s1.CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)s1.CC(CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(F)c(C(F)(F)F)c2)s1.C[C@H](CC(=O)c1cc(N2CCOCC2)ncn1)c1ncc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)s1.Cc1ccc(NC(=O)c2cc([C@@H](C)CC(=O)c3cc(N4CCOCC4)ncn3)no2)cc1C(F)(F)F.Cc1ccc(NC(=O)c2cnc(C(C)CC(=O)c3cc(N4CCOCC4)ncn3)s2)cc1C(F)(F)F.

What is the InChIKey of N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide?

The InChIKey is OGAKSHYZGUCCDL-WINPIKCYSA-N. The full InChI is InChI=1S/C24H24F3N5O4.C24H24F3N5O3S.C24H29N7O3S.2C23H21ClF3N5O3S.C23H21F4N5O3S/c1-14-3-4-16(10-17(14)24(25,26)27)30-23(34)21-11-18(31-36-21)15(2)9-20(33)19-12-22(29-13-28-19)32-5-7-35-8-6-32;1-14-3-4-16(10-17(14)24(25,26)27)31-22(34)20-12-28-23(36-20)15(2)9-19(33)18-11-21(30-13-29-18)32-5-7-35-8-6-32;1-15(9-17(32)16-10-21(29-13-26-16)31-5-7-34-8-6-31)23-25-12-18(35-23)22(33)30-20-11-19(24(2,3)4)27-14-28-20;3*1-13(8-18(33)17-10-20(30-12-29-17)32-4-6-35-7-5-32)22-28-11-19(36-22)21(34)31-14-2-3-16(24)15(9-14)23(25,26)27/h3-4,10-13,15H,5-9H2,1-2H3,(H,30,34);3-4,10-13,15H,5-9H2,1-2H3,(H,31,34);10-15H,5-9H2,1-4H3,(H,27,28,30,33);3*2-3,9-13H,4-8H2,1H3,(H,31,34)/t15-;;;13-;;/m0..1../s1.

What are the key properties of N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide?

N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide has a molecular weight of 3122.08 g/mol, XLogP of 27.17, 42 rotatable bonds, 6 hydrogen bond donors, and 50 hydrogen bond acceptors.

Where does this data come from?

All data for N-(6-tert-butylpyrimidin-4-yl)-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(2R)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-fluoro-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-3-[(2S)-4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,2-oxazole-5-carboxamide;N-[4-methyl-3-(trifluoromethyl)phenyl]-2-[4-(6-morpholin-4-ylpyrimidin-4-yl)-4-oxobutan-2-yl]-1,3-thiazole-5-carboxamide is sourced from PubChem (CID 159983144), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).